Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. (Q42837261)
Jump to navigation
Jump to search
scientific article published on 3 November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. |
scientific article published on 3 November 2010 |
Statements
1 reference
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. (English)
1 reference
1 reference
E M Migoya
1 reference
R Bergeron
1 reference
J L Miller
1 reference
R N K Snyder
1 reference
M Tanen
1 reference
D Hilliard
1 reference
B Weiss
1 reference
P Larson
1 reference
M Gutierrez
1 reference
G Jiang
1 reference
K A Pryor
1 reference
J Yao
1 reference
L Zhu
1 reference
G Herman
1 reference
N Thornberry
1 reference
J Amatruda
1 reference
D Williams-Herman
1 reference
J A Wagner
1 reference
R SinhaRoy
1 reference
3 November 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference